Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Helmer

Showing results (161-170 of 289) with videos related to

Pageof 29
Sort By:
Plos One|November 20, 2020
Free water: A marker of age-related modifications of the cingulum white matter and its association with cognitive declineManon Edde, Guillaume Theaud, François Rheault, et al.
Journal of the American Geriatrics Society|September 19, 2012
Is frailty a prodromal stage of vascular dementia? Results from the Three-City StudyJosé Alberto Avila-Funes, Laure Carcaillon, Catherine Helmer, et al.
CNS Drugs|February 22, 2015
Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanismsLaure Rouch, Philippe Cestac, Olivier Hanon, et al.
Neurology|November 3, 2025
Updated LIfestyle for BRAin health (LIBRA2) Score, Genetics, and Risk of Alzheimer Disease, Vascular Dementia, and Stroke in Older AdultsColin Rosenau, Jeanne Neuffer, Sebastian Köhler, et al.
Journal of the American Geriatrics Society|December 17, 2009
Higher level of systemic C-reactive protein is independently predictive of coronary heart disease in older community-dwelling adults: the three-city studyCeline Straczek, Pierre Ducimetiere, Pascale Barberger-Gateau, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 27, 2024
Prediction of dementia risk from multimodal repeated measures: The added value of brain MRI biomarkersAriane Bercu, Carole Dufouil, Stéphanie Debette, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 16, 2014
Plasma β-amyloid 40 levels are positively associated with mortality risks in the elderlyAudrey Gabelle, Susanna Schraen, Laure-Anne Gutierrez, et al.
JAMA|August 25, 2018
Association of Cardiovascular Health Level in Older Age With Cognitive Decline and Incident DementiaCécilia Samieri, Marie-Cécile Perier, Bamba Gaye, et al.
The Journal of Prevention of Alzheimer'S Disease|April 20, 2025
A six-year risk assessment for dementia and Alzheimer's disease in the general population through immunoprecipitation-mass spectrometry plasma amyloid quantificationGermain U Busto, Christophe Hirtz, Isabelle Carriere, et al.
Aging|June 6, 2017
Correction: Patterns of brain atrophy associated with episodic memory and semantic fluency decline in agingAmandine Pelletier, Charlotte Bernard, Bixente Dilharreguy, et al.
Pageof 29

Showing results (161-170 of 289) with videos related to

Sort By:
Pageof 29
Plos One|November 20, 2020
Free water: A marker of age-related modifications of the cingulum white matter and its association with cognitive declineManon Edde, Guillaume Theaud, François Rheault, et al.
Journal of the American Geriatrics Society|September 19, 2012
Is frailty a prodromal stage of vascular dementia? Results from the Three-City StudyJosé Alberto Avila-Funes, Laure Carcaillon, Catherine Helmer, et al.
CNS Drugs|February 22, 2015
Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanismsLaure Rouch, Philippe Cestac, Olivier Hanon, et al.
Neurology|November 3, 2025
Updated LIfestyle for BRAin health (LIBRA2) Score, Genetics, and Risk of Alzheimer Disease, Vascular Dementia, and Stroke in Older AdultsColin Rosenau, Jeanne Neuffer, Sebastian Köhler, et al.
Journal of the American Geriatrics Society|December 17, 2009
Higher level of systemic C-reactive protein is independently predictive of coronary heart disease in older community-dwelling adults: the three-city studyCeline Straczek, Pierre Ducimetiere, Pascale Barberger-Gateau, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 27, 2024
Prediction of dementia risk from multimodal repeated measures: The added value of brain MRI biomarkersAriane Bercu, Carole Dufouil, Stéphanie Debette, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 16, 2014
Plasma β-amyloid 40 levels are positively associated with mortality risks in the elderlyAudrey Gabelle, Susanna Schraen, Laure-Anne Gutierrez, et al.
JAMA|August 25, 2018
Association of Cardiovascular Health Level in Older Age With Cognitive Decline and Incident DementiaCécilia Samieri, Marie-Cécile Perier, Bamba Gaye, et al.
The Journal of Prevention of Alzheimer'S Disease|April 20, 2025
A six-year risk assessment for dementia and Alzheimer's disease in the general population through immunoprecipitation-mass spectrometry plasma amyloid quantificationGermain U Busto, Christophe Hirtz, Isabelle Carriere, et al.
Aging|June 6, 2017
Correction: Patterns of brain atrophy associated with episodic memory and semantic fluency decline in agingAmandine Pelletier, Charlotte Bernard, Bixente Dilharreguy, et al.
Pageof 29